Master Thesis
- UE code MSBMM208
- ECTS Credits 23
-
Language
English
Upon completion of this work, students will :
The major aim of the master thesis is to conduct a research project independently and to gain a first experience in the world of research professionals.
The second part of the master thesis comprises the redaction of a thesis manuscript, an oral presentation (in English) followed by a session of questions and answers in English as well.
Students will find a vademecum in WebCampus, which lays down the recommendations for the writing of the thesis manuscript and evaluation criteriea. The results will be introduced, presented clearly and assessed/discussed critically. Advancement(s) in the research field and perspectives will be pointed out.
The manuscript, the oral presentation and the defense will be assessed by a jury composed of four researchers.
The jury will grade (/20) the student following these guidelines: Manuscript (/10), Oral presentation and defense (/10)
The promoter will assign a unique note assessing the student’s work during the internship, the quality of the manuscript, the oral presentation and the defense (/20)
Final grade: Promoter (/10) + average note of the Jury (/10).
The exact modalities of the evaluation are likely to be modified during the preparation of the examination schedules, depending on the practical constraints with which the faculty administration may be confronted, or in the event of illness / force majeure / encroachment with an internship, or because of the health situation related to the coronavirus.
Pubmed and other bibliographical repositories.
Training | Study programme | Block | Credits | Mandatory |
---|---|---|---|---|
Master 120 en sciences biomédicales à finalité spécialisée en recherche préclinique | Standard | 0 | 23 | |
Master 120 en sciences biomédicales à finalité spécialisée en recherche clinique | Standard | 0 | 23 | |
Master 120 en sciences biomédicales à finalité spécialisée en recherche préclinique | Standard | 2 | 23 | |
Master 120 en sciences biomédicales à finalité spécialisée en recherche clinique | Standard | 2 | 23 |